Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | FABP3 | P05413 | 1/20 | 0.50 |
| ▸ | POLQ | O75417 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL44837 | 0.84 | IDO1 (0.57) | ALDH1A1POLQKMT2AIDO1KDM4E | |
| SCHEMBL29389277 | 0.84 | IDO1 (0.57) | ALDH1A1POLQKMT2AIDO1KDM4E | |
| SCHEMBL3628696 | 0.81 | ALDH1A1 (0.58) | ALDH1A1FABP4FABP3POLQEPHX2 | |
| SCHEMBL30449216 | 0.81 | LMNA (0.62) | ALDH1A1FABP4ALOX15TAS2R14GAA | |
| SCHEMBL221518 | 0.81 | LMNA (0.62) | ALDH1A1FABP4ALOX15TAS2R14GAA | |
| Alcohol SCHEMBL28201640 | 0.80 | LMNA (0.53) | ALDH1A1FABP4ALOX15TAS2R14GAA | |
| Alcohol SCHEMBL3628691 | 0.80 | ALDH1A1 (0.52) | ALDH1A1POLQTAS2R14LMNAPPARG | |
| SCHEMBL9461001 | 0.79 | LMNA (0.60) | ALDH1A1FABP4ALOX15TAS2R14GAA | |
| Hydrochloric Acid SCHEMBL2533965 | 0.79 | LMNA (0.60) | ALDH1A1FABP4ALOX15TAS2R14GAA | |
| SCHEMBL29208535 | 0.79 | LMNA (0.60) | ALDH1A1FABP4ALOX15TAS2R14GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101287692-B | Preparation method of optically active fluorobenzyl alcohol | CENTRAL GLASS CO LTD | 2012-06-06 | — | — | CN | disclosed |
| EP-1935866-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE FLUOROBENZYL ALCOHOL | CENTRAL GLASS CO LTD (JP) | 2011-12-14 | — | — | EP | disclosed |
| US-7795478-B2 | Process for producing optically active fluorobenzyl alcohol | CENTRAL GLASS COMPANY, LIMITED (JP) | 2010-09-14 | — | — | US | disclosed |
| US-20090240087-A1 | Process for Producing Optically Active Fluorobenzyl Alcohol | CENTRAL GLASS COMPANY, LIMITED (JP) | 2009-09-24 | — | — | US | disclosed |
| CN-101287692-A | Preparation method of optically active fluorobenzyl alcohol | CENTRAL GLASS CO LTD (JP) | 2008-10-15 | — | — | CN | disclosed |
| EP-1935866-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE FLUOROBENZYL ALCOHOL | Central Glass Company, Limited (JP) | 2008-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240087-A1 | Process for Producing Optically Active Fluorobenzyl Alcohol | ADH1A, ADH1C, ADH5 | ALDH1A1 47/4885FABP4 219/4885ALOX15 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.